ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA clears first magnetic, noninvasive device treatment for OCD
fiercebiotech
August 21, 2018The FDA granted de novo clearance to the first noninvasive device treatment for obsessive compulsive disorder, Brainsway’s transcranial magnetic stimulation system, adding a new therapy for adults alongside medication and psychotherapy.
Pharma Sources Insight January 2025
